Pharma News News & Articles

801 The Society of Hospital Medicine Expands Learning, Networking Opportunities for Hospitalists Full Text The Hospitalist, April 16, 2013

802 Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial Vaccine , April 16, 2013    Review Article

803 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Full Text Taro Pharmaceuticals USA, April 15, 2013

804 FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections Full Text BioPharm International, April 15, 2013

805 FDA Requests Almost $5 Billion for 2014 Budget Full Text BioPharm International, April 15, 2013

806 Teva to Report First Quarter 2013 Financial Results on May 2, 2013 Full Text Teva Pharmaceutical Industries, April 15, 2013

807 Brain Networks Activation technology Full Text Purdue Pharma, April 15, 2013

808 Mobidiag, Genewave and Amplidiag Announce Merger to Create a Leading Innovator in Molecular Diagnostics Full Text B3C newswire, April 15, 2013

809 Boston Scientific Launches Precision Spectra Spinal Cord Stimulator System In The United States Full Text Boston Scientific, April 15, 2013

810 Roche Will Use Technology From Isis To Develop Brain-disorder Drug Full Text BioPharm International, April 15, 2013

811 U-Florida: ID Theft a Risk for 14,000 Patients Full Text Health Data Management, April 15, 2013

812 Elan EGM Resolution Passed with over 99% Approval Full Text Elan, April 15, 2013

813 Bristol-Myers Squibb Plans Expansion of Massachusetts Biologics Facility Full Text BioPharm International, April 15, 2013

814 Burglary = 5,370 Breach Notifications Full Text Health Data Management, April 15, 2013

815 ONC Funds HIE Governance Work Full Text Health Data Management, April 15, 2013

816 Pfizer's Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer Full Text Pfizer, April 15, 2013

817 CDC issues recommendations for novel flu virus Full Text American Hospital Association News, April 15, 2013

818 Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetes Initiative Full Text Bristol Myers-Squibb, April 15, 2013

819 Bristol-Myers Squibb to Present New Data on Hepatitis C and Hepatitis B Compounds at The International Liver Congress (ILC) 2013 Full Text Bristol Myers-Squibb, April 15, 2013

820 Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire Full Text Bristol Myers-Squibb, April 15, 2013

1 Astellas pharma global development announces management reorganization Astellas, April 3, 2013    Free full text

2 Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States Abbott, April 16, 2013    Free full text

3 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013    Free full text

4 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013    Free full text

5 Statement on FOSAMAX (alendronate sodium) Product Liability Trial Merck, March 12, 2013    Free full text

6 FDA alerts providers to drug product recalls American Hospital Association News, March 29, 2013    Free full text

7 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013    Free full text

8 Alcon announces FDA approval of Simbrinza Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients Novartis, April 22, 2013    Free full text

9 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013    Free full text

10 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013    Free full text

11 US District Court rules one PULMICORT RESPULES (budesonide inhalation suspension) patent invalid and another patent not infringed AstraZeneca, April 2, 2013    Free full text

12 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013    Free full text

13 CEL-SCI Corporation Provides Update on Phase III Clinical Trial CEL-SCI, April 24, 2013    Free full text

14 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013    Free full text

15 Pfizer Issued Warning Letter for Italian Manufacturing Plant BioPharm International, April 12, 2013    Free full text

16 Valeant Pharmaceuticals Provides Update to Recent Event Valeant Pharmaceuticals International, April 5, 2013    Free full text

17 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013    Free full text

18 Astellas pharma us, inc. names new president Astellas, April 3, 2013    Free full text

19 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

20 Study: Tablets Can Effectively Read EEG Results Healthcare Informatics, April 5, 2013    Free full text